(3) included 100 COVID-19 patients compared to 70 healthy controls to identify biomarkers for assigning the risk of mortality, and demonstrated that CD8+ HLA‐DR+ T cells count significantly decreased in severe patients and may be the best biomarker for mortality outcome. Here, CD8A is linked to COVID-19.